(Q33888239)

29 July 2017

1 reference

title

Toward checkmate: biology and breast cancer therapy for the new millennium (English)

1 reference

29 July 2017

Miller KD

1

1 reference

PubMed ID

10759407

29 July 2017

Sledge GW Jr

series ordinal

2

1 reference

29 July 2017

1 January 1999

1 reference

Investigational New Drugs

29 July 2017

1 reference

29 July 2017

17

1 reference

29 July 2017

417-427

1 reference

29 July 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1006311227965

29 July 2017

0 references

cites work

Angiogenesis induced by "normal" human breast tissue: a probable marker for precancer.

1 reference

12 December 2020

Angiostatin induces and sustains dormancy of human primary tumors in mice

1 reference

12 December 2020

Requirement of vascular integrin alpha v beta 3 for angiogenesis

1 reference

12 December 2020

Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factors

1 reference

12 December 2020

Effects of retinoic acid and fenretinide on the c-erbB-2 expression, growth and cisplatin sensitivity of breast cancer cells

1 reference

12 December 2020

Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma.

1 reference

12 December 2020

Inhibition by Pentosan Polysulfate (PPS) of Heparin-Binding Growth Factors Released From Tumor Cells and Blockage by PPS of Tumor Growth in Animals

1 reference

12 December 2020

ER beta: identification and characterization of a novel human estrogen receptor

1 reference

12 December 2020

The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence

1 reference

12 December 2020

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

12 December 2020

Induction of apoptosis in MCF-7 breast carcinoma cell line by RAR and RXR selective retinoids.

1 reference

12 December 2020

The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT

1 reference

12 December 2020

Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptor

1 reference

12 December 2020

Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma

1 reference

12 December 2020

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

1 reference

12 December 2020

Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta

1 reference

12 December 2020

Association of Tumor Angiogenesis With Bone Marrow Micrometastases in Breast Cancer Patients

1 reference

12 December 2020

Switch to the angiogenic phenotype during tumorigenesis

1 reference

12 December 2020

Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells

1 reference

12 December 2020

Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

12 December 2020

Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human p

1 reference

12 December 2020

Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor

1 reference

12 December 2020

Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression

1 reference

12 December 2020

Follow-up study of HER-2/neu amplification in primary breast cancer.

1 reference

12 December 2020

Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer

1 reference

12 December 2020

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

12 December 2020

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

1 reference

12 December 2020

Serum and plasma M(r) 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma

1 reference

12 December 2020

Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors

1 reference

12 December 2020

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

12 December 2020

Angiogenesis-regulating cytokines: activities and interactions

1 reference

12 December 2020

Cloning of a novel receptor expressed in rat prostate and ovary

1 reference

12 December 2020

Gene therapy with p53 and a fragment of thrombospondin I inhibits human breast cancer in vivo

1 reference

12 December 2020

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.

1 reference

12 December 2020

Tyrosine kinase inhibition: an approach to drug development

1 reference

12 December 2020

Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu

1 reference

12 December 2020

Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials

1 reference

12 December 2020

Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth.

1 reference

12 December 2020

Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand.

1 reference

12 December 2020

Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration

1 reference

12 December 2020

Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.

1 reference

12 December 2020

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

1 reference

12 December 2020

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

12 December 2020

Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.

1 reference

12 December 2020

Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution

1 reference

12 December 2020

IGF-1 receptor as the restriction point of the cell cycle

1 reference

12 December 2020

Insulin-like growth factors: the unrecognised oncogenes

1 reference

12 December 2020

SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types

1 reference

12 December 2020

Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma

1 reference

12 December 2020

Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans

1 reference

12 December 2020

Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4.

1 reference

12 December 2020

Targeted toxin therapy for the treatment of cancer

1 reference

12 December 2020

Growth factors in breast cancer

1 reference

12 December 2020

Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes.

1 reference

12 December 2020

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

12 December 2020

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1 reference

12 December 2020

Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ.

1 reference

12 December 2020

Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins

1 reference

12 December 2020

Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis

1 reference

12 December 2020

Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo

1 reference

12 December 2020

Is the relationship between angiogenesis and metastasis in breast cancer real?

1 reference

12 December 2020

Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells

1 reference

12 December 2020

Laminin receptors, collagenase IV and prognosis in node-negative breast cancers

1 reference

12 December 2020

Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest

1 reference

12 December 2020

ERBB2 oncogene in human breast cancer and its clinical significance

1 reference

12 December 2020

Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer

1 reference

12 December 2020

Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells

1 reference

12 December 2020

Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

1 reference

12 December 2020

Antiangiogenic effects of camptothecin analogues 9-amino-20(S)-camptothecin, topotecan, and CPT-11 studied in the mouse cornea model

1 reference

12 December 2020

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

12 December 2020

The strategic use of antiestrogens to control the development and growth of breast cancer.

1 reference

12 December 2020

Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth

1 reference

12 December 2020

Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice

1 reference

12 December 2020

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

1 reference

12 December 2020

Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein

1 reference

12 December 2020

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

12 December 2020

Association between tumour angiogenesis and tumour cell shedding into effluent venous blood during breast cancer surgery

1 reference

12 December 2020

Tamoxifen down-regulates CD36 messenger RNA levels in normal and neoplastic human breast tissues.

1 reference

12 December 2020

Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer

1 reference

12 December 2020

Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo

1 reference

12 December 2020

Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases.

1 reference

12 December 2020

Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.

1 reference

12 December 2020

Clinical potential of new antiestrogens

1 reference

12 December 2020

Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer.

1 reference

12 December 2020

Somatic genetic changes in human breast cancer

1 reference

12 December 2020

Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma.

1 reference

12 December 2020

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma

1 reference

12 December 2020

Angiogenesis inhibition by minocycline

1 reference

12 December 2020

The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice

1 reference

12 December 2020

Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer

1 reference

12 December 2020

Inhibition of breast cancer in nude mouse model by anti-angiogenesis

1 reference

12 December 2020

Interstitial collagenase is required for angiogenesis in vitro

1 reference

12 December 2020

Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma

1 reference

12 December 2020

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

1 reference

12 December 2020

Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients

1 reference

12 December 2020

Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy

1 reference

12 December 2020

Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin

1 reference

12 December 2020

Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1.

1 reference

12 December 2020

Effects of surgery on the cell kinetics of residual tumor

1 reference

12 December 2020

Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol

1 reference

12 December 2020

Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells

1 reference

12 December 2020

Suramin inhibits the growth of human breast cancer cell lines. Studies on parental lines and corresponding sublines with acquired doxorubicin resistance with and without expression of P-glycoprotein

1 reference

12 December 2020

Selective modulation of collagenase 1 gene expression by the chemotherapeutic agent doxorubicin

1 reference

12 December 2020

Presence of a growth-stimulating factor in serum following primary tumor removal in mice

1 reference

12 December 2020

Angiogenesis: A Marker for Neoplastic Transformation of Mammary Papillary Hyperplasia

1 reference

12 December 2020

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

1 reference

12 December 2020

Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.

1 reference

12 December 2020

Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells

1 reference

12 December 2020

Inhibition of Angiogenesis and Murine Hemangioma Growth by Batimastat, a Synthetic Inhibitor of Matrix Metalloproteinases

1 reference

12 December 2020

HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study

1 reference

12 December 2020

Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption

1 reference

12 December 2020

Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.

1 reference

12 December 2020

Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity

1 reference

12 December 2020

Effects of doxycycline on in vitro growth, migration, and gelatinase activity of breast carcinoma cells

1 reference

12 December 2020

Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue

1 reference

12 December 2020

Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma--results of a multiparametric study.

1 reference

12 December 2020

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.

1 reference

12 December 2020

c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer

1 reference

12 December 2020

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

12 December 2020

The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast

1 reference

12 December 2020

Antibody-directed targeting of the vasculature of solid tumors

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1006311227965

1 reference

PubMed ID

10759407

Dimensions Publication ID

29 July 2017

0 references

1 reference

PubMed ID

10759407